title: [Silent myocardial ischemia. Arguments in favor of treatment].
authors.affiliation: Servicio de Cardiología, Hospital de Navarra, Pamplona.
authors.forename: R
authors.initials: R
authors.lastname: Lezaun
authors.forename: C
authors.initials: C
authors.lastname: Maraví
authors.forename: H
authors.initials: H
authors.lastname: Gervás
authors.forename: I
authors.initials: I
authors.lastname: Madariaga
authors.forename: N
authors.initials: N
authors.lastname: Basterra
authors.forename: E
authors.initials: E
authors.lastname: de los Arcos
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy; D000789:Angina, Unstable / Q000175:diagnosis / Q000188:drug therapy; D001262:Atenolol / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D015716:Electrocardiography, Ambulatory; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D009204:Myocardial Revascularization; D011379:Prognosis; D011446:Prospective Studies; D013565:Sympatholytics / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D013565:Sympatholytics; D001262:Atenolol
vernacular_title: Isquemia miocárdica silente. Argumentos a favor de su tratamiento.